Rome Didn't Fall in A Day.









Objective Truth Exists and is Accessible to Everyone.

All Human Problems can be Solved with Enough Knowledge, Wealth, Social Cooperation and Time.


Photo: Rusty Peak, Anchorage, Alaska


Translate

Sunday, November 16, 2014

To Care For a Woman's Heart

Heart disease kills women and men in roughly equal numbers.   And nearly equal numbers of women and men suffer from high cholesterol, which is a leading cause of heart disease.   But our health system cares for the hearts of men and neglects the hearts of women.

Medical guidelines decree that men over 35 years of age should have cholesterol screening as part of the standard health maintenance.   Cholesterol screening for men is paid by insurance, as required by the Affordable Care Act.  However, cholesterol screening for women is not covered by insurance, unless the woman has known risk factors and brings those factors to the attention of the doctor.  If a healthy woman is interested in cholesterol screening, she must pay for the test herself.

About two-thirds of the women who die suddenly from heart disease have no previous symptoms and are unaware of their risk.  High cholesterol is easy and inexpensive to control, if the condition is recognized.  Screening for high cholesterol should be one of the most basic components of a health maintenance program for women, to prevent illness and death from heart disease. 

A publication from the CDC clearly states that heart disease should no longer be regarded as a “man’s disease”.   But guidelines from medical authorities, our laws, and our health insurance are not in accordance with that view.
---
It is interesting to compare fact sheets published by the Centers for Disease Control (CDC) for Men’s Heart Health and Women’s Heart Health.   The publications can be found here:

The publications are generally parallel, as seen in the following quotes.

Women
·         Heart disease is the leading cause of death for women in the United States, killing 292,188 women in 2009—that’s 1 in every 4 female deaths.
·         Heart disease is the leading cause of death for African American and white women in the United States.
·         About 5.8% of all white women, 7.6% of black women, and 5.6% of Mexican American women have coronary heart disease.
·         Almost two-thirds (64%) of women who die suddenly of coronary heart disease have no previous symptoms. Even if you have no symptoms, you may still be at risk for heart disease.
·         High blood pressure, high LDL cholesterol, and smoking are key risk factors for heart disease. About half of Americans (49%) have at least one of these three risk factors.

Men
·         Heart disease is the leading cause of death for men in the United States, killing 307,225 men in 2009—that’s 1 in every 4 male deaths.
·         Heart disease is the leading cause of death for men of most racial/ethnic groups in the United States, including African Americans, American Indians or Alaska Natives, Hispanics, and whites.
·         About 8.5% of all white men, 7.9% of black men, and 6.3% of Mexican American men have coronary heart disease.
·         Half of the men who die suddenly of coronary heart disease have no previous symptoms. Even if you have no symptoms, you may still be at risk for heart disease.
·         High blood pressure, high LDL cholesterol, and smoking are key risk factors for heart disease. About half of Americans (49%) have at least one of these three risk factors.

The Women’s Heart Health Fact Sheet includes two sections not contained in the Men’s Fact Sheet.  One section addresses symptoms of heart disease, and the other section addresses health screening, including cholesterol screening.  Women are advised to discuss cholesterol testing with their doctor, and proceed with screening if the woman has any of several risk factors for heart disease.

However, the CDC Men’s Fact Sheet publication is silent about cholesterol screening.  The reason for the omission is simple: men’s cholesterol screening is the default recommendation under guidelines of the Affordable Care Act, and according to guidelines issued by the American College of Cardiology/American Heart Association (CDC/AHA).  No discussion is needed for the man.  The doctor will perform a cholesterol screening for every man over 35, as part of his annual wellness physical exam.  The doctor may not perform the screening for women, unless she has a risk factor and brings it to the attention of the doctor, or she specifically requests the test. 

Guidelines for preventive treatment of heart disease are established by the CDC and the ACC/AHA.  These guidelines are transformed into policies, in both meanings of the word.  The discriminatory guidelines are enshrined as policy in the fine print of the Affordable Care Act (ObamaCare), and as the terms of insurance policies governed by the legislation.  Thus, a man’s annual cholesterol test will be paid for by his insurance.  If a woman asks for a cholesterol test and doesn’t present any of the risk factors, she must pay for the test herself.

Prevalence of high LDL-c Cholesterol in Men and Women
Based on data from 2005 – 2008, an estimated 71 million adult Americans have levels of LDL-c (bad) cholesterol above recommended guideline.  About half of those receive treatment, with about two-thirds of treated patients achieving success in lowering LDL-c cholesterol below the recommended threshold. 

There is a small, but immaterial difference between men and women in the prevalence of high LDL-c cholesterol.  About 36 percent of adult men (> age 20) have high levels of bad cholesterol, while about 31 percent of adult women have high levels of bad cholesterol, based on data from 2005 - 2008.  Using these ratios and current population figures, about 39 million American men are in need of cholesterol screening and treatment, while about 36 million American women are in need of cholesterol screening and treatment.

Effectiveness of Cholesterol Screening and Control
Treatment of high LDL-c cholesterol is improving in effectiveness.   In comparing data from 1999-2002 to data from 2005-2008, the percentage of patients receiving treatment for high LDL-c cholesterol increased from 30% of affected patients to about 50% of affected patients.  Also, the percentage of patients successfully controlling high cholesterol more than doubled, from 15% to 33% of all patients.  Recognition of patients with high cholesterol is clearly essential to prescribing treatment and successfully controlling the condition.

Cholesterol screening is simple.   Treatment of high cholesterol is effective and low-cost.  Millions of women are at nearly equal risk with men regarding heart disease, and there is no reason why there should be a difference in standard guidelines for cholesterol screening and insurance coverage of the procedure.

Differences between Women’s and Men’s Heart Health
There are differences in women’s and men’s heart health.  In the interest of objectivity, I’ll look at those differences in this section.

First, as noted above, more men than women suffer from high LDL-c (bad) cholesterol.   The percentage of men with high bad cholesterol is about 36%, while the percentage of woman with bad cholesterol is about 31%.  Still that leaves 36 million women with a treatable condition that places them at risk of sudden death. 

Second, men tend to die of heart disease at a younger age than women.  Let’s look at two maps presented on the fact sheets prepared by the CDC.  These show the age-corrected death rates from heart disease for men and women.
Superficially, the maps appear almost identical.  But the scaling on the maps is different.   All of the women’s categories except the highest level would be displayed as the lightest color on the men’s map.  If the maps were displayed with the same color scale, the woman’s map would be much lighter than the men’s map.   On an age-corrected basis, the women’s death rate from heart disease is visibly lower than the men’s rate.  I would need addition information about the age-corrected death rate to quantify the difference.

Third, men’s heart attacks tend to be more sudden and incapacitating than women’s heart attacks, according to various literature.  A man’s stereotypical heart attack is traumatic and catastrophic, while a woman’s heart attack is a subtle and silent killer.  Thus, men’s heart disease attracts the attention of the public and medical community, while women’s heart disease is ignored.
While acknowledging these differences exist, it seems to me that they do not justify systematically neglecting women’s cholesterol and heart health.   It should be noted that the death rates from heart disease for women between the ages of 29 and 45 have been rising since the year 2000.

Conclusion
Cholesterol testing addresses the number one killer of American women, and should be a standard preventative health treatment for women.  Testing for cholesterol will also help communicate the risk of heart disease to women, and prompt discussion with patients about other risk factors, such as blood pressure and life style, that may also lead to heart disease or other illnesses. 
Strangely, the CDC Fact Sheet on Women and Heart Disease includes this acknowledgement:
“Although heart disease is sometimes thought of as a ‘man's disease’, around the same number of women and men die each year of heart disease in the United States.  Despite increases in awareness over the past decade, only 54% of women recognize that heart disease is their number 1 killer.”

However, the entire medical establishment, as represented by CDC fact sheets, the guidelines of the ACC/AHA, and the provisions of the Affordable Care Act, continues to regard heart disease as a ‘man’s disease’.   Men receive automatic cholesterol screening, paid for by insurance, to reduce their risk of illness and death.  Women must specifically inquire about screening, and in most cases pay for the screening themselves, while they face nearly equal odds of preventable illness and death. 

That’s just not right.

---
Related information
Actress and singer Barbara Streisand has become an activist for women’s heart health.  Streisand’s philanthropy supports the Barbara Streisand Women’s Heart Center, at the Cedars-Sinai Medical Center in Los Angeles.  Streisand also founded the Women’s Heart Alliance.  The Women’s Heart Alliance recently launched a campaign for women’s heart health called “Fight the Ladykiller”.  Links are included in references listed below.
----
References
Women and Heart Disease Fact Sheet; Centers for Disease Control.

Men and Heart Disease Fact Sheet; Centers for Disease Control.

Vital Signs: Prevalence, Treatment, and Control of High Levels of Low-Density Lipoprotein Cholesterol --- United States, 1999--2002 and 2005—2008, Morbidity and Mortality Weekly Report (MMWR), Centers for Disease Control and Prevention, February 4, 2011 / 60(04);109-114.

Million Hearts Program, Centers for Disease Control.
Strategies that address leading Cardio-Vascular Disease (CVD) risk factors, such as hypertension, high cholesterol levels and smoking, that can greatly reduce the burden of CVD.

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic
Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Preventative Health Care Services for Women, Healthcare.gov.
Health care services under the ACA; there is no immediate mention of different cholesterol screening for men and women, on these websites, until you drill down to the following page on HealthFinder.gov.

Get your cholesterol checked, HealthFinder.gov
Different standards for women’s and men’s  cholesterol screening.

Population by Age and Sex, 2012, US Census Bureau

Barbara Streisand and Women’s Heart Health


Friday, November 7, 2014

Charting the 2014 Ebola Epidemic; March 11th Update

The following charts are updates to previous posts about the Ebola epidemic in West Africa. 
I will update these charts as new data becomes available.
Additional resources may be found at StopEbola.uk:

April 29, 2015
My latest update regarding the history of the Ebola epidemic can be found here:
http://dougrobbins.blogspot.com/2015/04/ro-and-history-of-ebola-epidemic-in.html
------------------------------------
March 11, 2015
Data from the World Health Organization is complete through March 8.

The exponential rate of growth observed in the initial months of the epidemic was broken in mid-October, 2014.   The rate of disease transmission fell from early December, 2014 to mid-January, 2015.  Since that time, the rate of transmission has remained fairly constant at about 50 new cases per day.  The most recent data indicates a slight increase in the rate of transmission.  The geographic dispersion of new cases is also a serious concern.

The Ro history for the epidemic has been calculated, and appears at the bottom of this update. Ro represents the rate of new disease transmission, with the number representing the number of new cases generated by each case of Ebola.  An Ro value greater than 1 means the epidemic is growing, and a value less than 1 means the epidemic is diminishing.  Ro approached 1.3 during the period of most rapid growth, and has been approximately 0.9 while epidemic declined.  A recent rise in Ro is noted, and is of some concern.

The most important chart of the Ebola epidemic is now the chart of daily new cases.  Daily new cases have been falling since early December, after peaking around 160 new cases per day. New cases fell to about 50 cases per day in the second week of January.  Since that time, the rate of transmission has stalled at about 50 new cases per day, with a slight uptick in the rate of transmission seen in the latest data.

The current rate of 50 new cases per day was last seen in early August, 2014.  This rate of disease transmission is still a tragedy, and still dangerous.  Ebola is a disease capable of explosive growth, and cannot be considered contained until it is eradicated.

The locus of disease transmission in West Africa has shifted westward, from Liberia to Sierra Leone and western Guinea.  The dispersion of new cases is also a concern.  In the last two weeks, new cases have appeared in four provinces of Guinea which border Senegal, Mali, and Cote d'Ivoire.  Intervention efforts must remain flexible to meet the disease wherever it appears.


Sierra Leone remains the most active area of Ebola transmission.
The chart of cumulative cases has taken on the S-shaped curve, indicating decline in the rate of transmission, but has not approached a zero rate of transmission.

Ro is the parameter which indicates the rate of transmission for an epidemic.  The number Ro indicates the number of subsequent new cases, on average, generated by each case.  Thus, an Ro value larger than 1 indicates a growing epidemic; an Ro value less than one indicates the epidemic is shrinking.  
I applied a 3rd-degree polynomial regression to three parts of the cumulative case chart.  (The entire case history was too complicated to represent well with a single expression, and contains some large data revisions in the middle of the epidemic.)   I used the regressions to smooth the data, and calculate the daily new cases, and the rate of Ebola transmission, assuming an average 8-day lag between infections.  
From these regressions, I calculated Ro for the history of the epidemic.
The epidemic grew quite rapidly during the period when Ro exceeded 1.2, in part due to the extremely rapid course of the disease.  Ro fell below 1 in late September, and the growth of the epidemic declined substantially.  New cases in Liberia are approaching zero, but the main locus of transmission has shifted westward, into Sierra Leone.  In the fall of 2014, the World Health Organization set a goal of placing 70 percent of patients in isolation, after which WHO anticipated ending the epidemic by January 2015.   Clearly, the desired level of disease transmission was not achieved, and the epidemic did not end.

Ro approached 0.9, at its lowest point.  While the number of new cases is still declining, Ro has begun rising again, which is a matter of serious concern.
---------------------------------------------------------------------------------------------------------------------
My previous posts on the Ebola topic can be viewed here:

Previous Posts
Discusses the exponential rate of growth of the epidemic, and likely future changes to the pathogen.
Discusses the inadequacy of the medical response in terms of a linear response to an exponentially growing problem.
Discusses the geographic distribution of populations corresponding to points on the exponential extrapolation.

References
http://www.who.int/csr/disease/ebola/situation-reports/en/

Infighting among health authorities fighting the Ebola epidemic.

----

Obsolete Updates
February 13, 2015
Data from the World Health Organization is complete through February 8.

The exponential rate of growth observed in the initial months of the epidemic was broken in mid-October, 2014.   The rate of disease transmission fell from early December, 2014 to mid-January, 2015.  Since that time, the rate of transmission has remained fairly constant at about 50 new cases per day.  The most recent data indicates a slight increase in the rate of transmission.  The geographic dispersion of new cases is also a serious concern.

The most important chart of the Ebola epidemic is now the chart of daily new cases.  Daily new cases have been falling since early December, after peaking around 160 new cases per day. New cases fell to about 50 cases per day in the second week of January.  Since that time, the rate of transmission has stalled at about 50 new cases per day, with a slight uptick in the rate of transmission seen in the latest data.

The current rate of 50 new cases per day was last seen in early August, 2014.  This rate of disease transmission is still a tragedy, and still dangerous.  Ebola is a disease capable of explosive growth, and cannot be considered contained until it is eradicated.


The locus of disease transmission in West Africa has shifted westward, from Liberia to Sierra Leone and western Guinea.  The dispersion of new cases is also a concern.  In the last two weeks, new cases have appeared in four provinces of Guinea which border Senegal, Mali, and Cote d'Ivoire.  Intervention efforts must remain flexible to meet the disease wherever it appears.



The following charts are updates to the original extrapolations made on this blog in early August.  
The Ebola Response Roadmap issued by the World Health Organization on August 28, acknowledged that the aggregate case load could exceed 20,000 cases, which I considered unrealistically optimistic at the time.  The reduction in the rate of growth to date, remarkably, appears to meet the projections of the WHO roadmap.  It is a credit to the all of the organizations working to end the epidemic to see the progress made to date.  But the job is not complete, and the situation remains dangerous, as long as the disease continues to spread in Sierra Leone, or any other locality.


January 15, 2015
Data from the World Health Organization is complete through February 1.  Case numbers from Liberia continue to lag data from Sierra Leone and Guinea.

The exponential rate of growth observed in the initial months of the epidemic was broken in mid-October, 2014.   The rate of disease transmission has been falling since early December, 2014.

The most important chart of the Ebola epidemic is now the chart of daily new cases.  Daily new cases have been falling since early December, after peaking around 160 new cases per day. New cases fell to about 100 cases per day in early January, and are now trending downward at about 50 new cases per day.   

The current rate of 50 new cases per day was last seen in early August, 2014.  This rate of disease transmission is still a tragedy, and still dangerous.  The locus of disease transmission in West Africa has shifted westward, from Liberia to Sierra Leone and western Guinea.  Intervention efforts must remain flexible to meet the disease wherever it appears.

December 24, 2014
Data from the World Health Organization is complete through December 20.  Case numbers from Liberia continue to lag data from Sierra Leone and Guinea.

The exponential rate of growth observed in the initial months of the epidemic was broken in mid-October, 2014.  If the original rate of growth had continued, cumulative cases would number about 45,000, rather than the current figure of 19,400.  A tragic number of new cases are still occurring.   Over 100 people are still falling ill with Ebola every day.

The rate of daily new cases is falling, but erratically.  The number of daily new cases is persistently high, and not far below the peak number of cases seen in October and November.
December 1, 2014
Data released on December 1 2014 by the World Health Organization shows that the epidemic set a new record in the number of daily new cases, exceeding 200 new cases per day.  The interpolated and smoothed chart below also shows a new record of 161 new cases per day.

The daily number of new cases had been declining from early November through November 17, raising hopes that the epidemic was coming under control.  However, the latest case numbers from Liberia and Sierra Leone have sharply reversed that trend.  These numbers are insufficient to draw clear conclusions, as we have only a few data points.  But the reversal of the declining trend and the new record of daily new cases are extremely troubling.

As progress is made against the epidemic, the most dangerous opponent may be complacency.
November 29, 2014
The growth rate of reported Ebola cases has stabilized when considering the entire epidemic.   There has been a sharp reduction in the rate of transmission in Liberia.  However, gains in Liberia are offset by a continuing high rate of transmission in Sierra Leone, as seen in the following charts of cumulative cases by country, on linear and logarithmic scales.  The epidemic continues to grow at a nearly exponential rate in Sierra Leone, with only slight improvement noted in the past two weeks.

The following charts are updates to the original extrapolations made on this blog in early August.
  
The Ebola Response Roadmap issued by the World Health Organization on August 28, acknowledged that the aggregate case load could exceed 20,000 cases, which I considered unrealistically optimistic at the time.  The reduction in the rate of growth to date, remarkably, appears to meet the projections of the WHO roadmap.  It is a credit to the all of the organizations working to end the epidemic to see the progress made to date.  But the job is not complete, and the situation remains dangerous, as long as the disease continues to spread in Sierra Leone, or any other locality.



November 21, 2014
Figures from the World Health Organization show a continuing trend of improvement in the cumulative number of Ebola Cases.  Rates of transmission are falling in Guinea and Liberia, although the daily number of new cases is still rising in Sierra Leone.  The falling rate of transmission in Liberia indicates success in educating the public about the disease and implementing basic public health measures.   At this time, only 18 of 53 planned Ebola treatment centers are open.  The epidemic is diminishing due to success in changing behaviors which contributed to the spread of the disease.

Six cases have now been reported in Mali, which borders Guinea to the north.  Contacts from these cases are being traces.  Still new infections in Mali represent a troubling extension of the disease into the interior of Africa, and outside the countries with intensive efforts to quell the epidemic.

Like firefighters working to control a wildfire, efforts to quell the epidemic must continue unabated as long a sparks remain. The official number of daily new cases is now about 150, down from 170 about two weeks ago.  There is good reason to be hopeful, but the fire is still burning.

----
The following chart is the number of reported daily new cases of Ebola, interpolated and smoothed with a nine-day rolling average.  The exponential rate of growth was broken in mid-September.   Recent data is distorted by data revisions, but appears to have settled around 150 new cases per day. There are hopeful signs of a decline in new cases over the past two weeks, but there are still great doubts about the accuracy of the official case numbers.  Dr. Hans Rosling, epidemiologist acting as consultant to Liberia's Health Ministry, stated on November 5, "We are absolutely sure that we cannot be sure about the data."

Death rates calculated from reported cases continue to fall.  While a decline in death rates is expected, the magnitude of decline seems improbable.  WHO also reports substantial under-reporting of Ebola deaths.  This should be of concern to health authorities, because it means that many burials are not being conducted according to safety protocols.


November 14, 2014

The latest figures from the World Health Organization show a continuing trend of improvement in the cumulative number of Ebola Cases.  Rates of transmission are falling in Guinea and Liberia, although the number of cases is now rising sharply in Sierra Leone.  The falling rate of transmission in Liberia indicates success in educating the public about the disease and implementing basic public health measures.   At this time, only 17 of 53 planned Ebola treatment centers are open.  The epidemic is diminishing due to success in changing behaviors which contributed to the spread of the disease.

Four cases have been reported in Mali, which borders Guinea to the north.  The three new cases are unrelated to the previously reported case, and represent a troubling extension of the disease into the interior of Africa, and outside the countries with intensive efforts to quell the epidemic.

Like firefighters working to control a wildfire, efforts to quell the epidemic must continue unabated as long a sparks remain.  The epidemic is still growing at a rate of about 160 new cases a day.  By comparison, in July of this year, the rate of transmission was about 20 cases a day.  The world was unable to control the epidemic at that level.

There is good reason to be hopeful, but the fire is still burning.

November 7, 2014

There are definite indications that the Ebola epidemic in Liberia is easing.  Anecdotal reports indicate there are beds available in treatment centers, and burial teams are collecting fewer bodies from the city.  Official numbers are unfortunately still highly questionable, with recent changes dominated by revisions, rather than by new cases.  Following a large upward revision on October 25, there has been an almost unbelievably low of number of reported new cases.   Recent case numbers in Sierra 
Leone are also dominated by revisions to previous estimates, but large numbers of new cases are still being reported. 

Avoidance of official treatment centers is still a problem, due to fear and cultural objections to the approved safe burial practices and/or cremation. 



The following charts were prepared from case numbers issued by the World Health Organizations.  Case numbers are subject to study and subsequent revision.  Reporting from the affected countries has been somewhat erratic, and at irregular intervals.  I interpolated the cumulative number of cases in certain countries to obtain discrete reporting dates for the entire epidemic.



The exponential extrapolation is the original extrapolation, created by an exponential regression to the data from May 23 to August 26, with days beginning on May 23.  Despite the recent positive reports from West Africa, data continues to fall near the line of the original extrapolation.